Article Processing Fee
The Journal receives no government, educational, charitable or any other kind of funding. We do not accept advertisements. Therefore, we publish the journal based on the article processing fees obtained from the authors. Submission of a manuscript and peer-review processes are free of charge. An article-processing fee applies only to accepted manuscripts. If a paper is accepted for publication, the authors need to pay a publication processing fee equal to 2400 EURO prior to proof. Publishing fees or waiver status will not influence editorial decision making.
Article Processing Fee covers the cost of open access manuscript, journal production, web hosting, CMS, database, online repository, archiving, XML conversion, reference formatting, unlimited number of color figures, and free extensive English editing.
Guidelines for Authors to Submit a Manuscript
The paper should be unique and not published elsewhere. All authors should read and approve authorship responsibility and publication ethics principles presented on our website. All authors should provide a competing interest statement. One author has been entitled as the corresponding author with contact details and postal address. All abstracts should be structured effective from May 2020 onward. The following types of manuscripts could be submitted: original article, review article, editorial, letter, hypothesis, and case reports (preferably with a comprehensive literature review).
Requirements for Different Types of Articles
Original articles: Should contain a structured abstract, 3-5 keywords, introduction, methods, results, discussion, conclusion, ethical declaration, acknowledgment, funding, and references. There is no restriction on word numbers and supporting documents. RCTs should be registered at any RCT Registriest approved by the WHO.
Case reports (preferably with a comprehensive literature review): Should contain a structured abstract, 3-5 keywords, introduction, case presentation, discussion, conclusion, ethical declaration, acknowledgment, funding, and references. Informed consent should be obtained from the patients to report their cases. The Journal keeps the right to ask for original signed informed consent.
Review articles: Review articles, systematic reviews or meta-analyses are most welcome. The protocol of the study should adhere to PRISMA guidelines.
Editorials and letters: Letters and editorials should be preferably less than 2500 words. Those letters discussing articles published in the journal should be submitted at most within 6 months after the publication of the main article. Editorials and letters will undergo the peer-review process. These articles have no abstracts.
Hypothesis: The main body of this manuscript consists of an introduction, hypothesis, evaluation of hypothesis, discussion, and conclusions. The structural abstract in this type should consist of background, hypothesis, and conclusions.
Manuscripts should be prepared based on the following segments:
A cover letter that contains the rationale of performing the research and a statement that you will not resubmit your article to another journal until the reviewing process will be completed. Also please indicate whether the authors have published or submitted any related papers from the same study to prevent salami plagiarism.
Title page should include the title of study, name of authors (with an email address), and their affiliations as the first page of the manuscript. Complete mailing address, telephone number, and email address of the corresponding author should be mentioned.
Abstract, less than 300 words, structural, concise, and comprehensible to readers. Keywords are used for indexing purposes; three to five keywords should be selected from the Medical Subject Headings (MeSH).
Introduction should cover a short background of former studies and potential gaps in the literature, and specify the aim of the study.
Methods should indicate evidently the stepwise approach taken to acquire the data including statistical analysis. It should be detailed mention inclusion and exclusion criteria and preferably presented in separated subsections. For reports of randomized controlled trials, authors should refer to the CONSORT statement. Reporting guidelines such as STROBE, STARD, and PRISMA would help authors to present high-quality study and to deliver all required information and evidence. EQUATOR Network website would assist authors in using these guidelines.
Results should be presented in chronological order in the text, table, and illustration. Tables and figures must be cited in order in which they appear in the text, and present with the separate legend and reveal all abbreviations. Tables should be simple include titles, descriptions, footnotes and ensure all figures and tables have been cited in the text. Do not present tables with duplicate information in the text of the paper. Figures should be provided only if they add further information. High-resolution figures in TIFF format with dpi of 600 should be presented. If you have reused or adapted figures, tables or sections of text from papers published elsewhere please approach the copyright owner and obtain their permission to re-use those elements.
Discussion should challenge the outcomes of the research with other publications in the literature in the format of arguments and counterarguments. The limitations and strengths of the study and the implications of the findings for future study or clinical practice should be presented.
Conclusion should present the final outcome and brief recommendations that have been reached.
Ethical declaration consists of ethical approval and conflict of interest that should be presented and reported.
References should be complied numerically according to the order of citation in the text. We follow the Vancouver style, as outlined as PubMed style. For various references please refer to the NLM style guide for authors, editors, and publishers. All references cited in the reference segment should be cited in the text.
